Literature DB >> 10389991

Characterization of the model for experimental testicular teratoma in 129/SvJ-mice.

J Sundström1, L J Pelliniemi, T Kuopio, E Veräjänkorva, K Fröjdman, V Harley, E Salminen, P Pöllänen.   

Abstract

An animal model of experimental testicular teratoma has been established to study how a teratoma affects the host testis and how the host testis reacts against the teratoma. 129/SvJ-mice were used as experimental animals. To induce the experimental testicular teratoma, male gonadal ridges from 12-day-old 129/SvJ-mouse fetuses were grafted into the testes of adult mice for 1-12 weeks. The developing tumour was analysed by light and electron microscopy and by immunocytochemical localization of transcription factors SOX9 and c-kit, glial fibrillary acidic protein (GFAP) and type IV collagen. Testicular teratoma was observed in 36 out of 124 testes with implanted fetal gonadal ridges (frequency 29%). One spontaneous testicular teratoma was observed in this material from 70 male mice (1.5%). One week after implantation intracordal clusters of cells were seen in embryonic testicular cords of the graft as the first sign of testicular teratomas. Four weeks after implantation the embryonic testicular cords had totally disappeared from grafts with teratomas, and the tumour tissue had enlarged the testis and invaded the interstitium of the host testis. It consisted of solitary pieces of immature cartilage as well as of glial cells and of primitive neuroepithelium. Six to eight weeks after implantation the tumour tissue had expanded so that the enlarged testis could be detected by macroscopic enlargement of the scrotum. The testicular tissue of the host had practically disappeared, and only solitary disrupted seminiferous tubules of the host were seen surrounding the teratoma. Neuroepithelial structures of some teratomas cultured for 8 weeks had cells with a granular nucleus as a sign of obvious apoptosis. Eleven to 12 weeks after implantation the growth of the teratoma had stopped, and the histology corresponded to that of a mature cystic teratoma. GFAP, SOX9 and type IV collagen were strongly positive in some parts of the tumours cultured for 4 and 8 weeks, while only occasional c-kit-positive areas were observed in tumours cultured for 8 weeks. As conclusions: (1) the metastasizing capacity of the experimental testicular teratoma is very low during 12 weeks, but the behaviour of the tumour in the testicular tissue of the graft is invasive; (2) the growth of experimental testicular teratomas cease 6-8 weeks after implantation of the fetal gonadal ridges with the obvious apoptosis of the immature tissue components; (3) the model of experimental testicular teratoma in the mouse is suitable for studying how the teratoma affects the host testis and how the host testis reacts to teratoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389991      PMCID: PMC2363015          DOI: 10.1038/sj.bjc.6690334

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

Review 1.  Evidence for decreasing quality of semen during past 50 years.

Authors:  E Carlsen; A Giwercman; N Keiding; N E Skakkebaek
Journal:  BMJ       Date:  1992-09-12

2.  Studies on transplantable testicular teratomas of strain 129 mice.

Authors:  L C STEVENS
Journal:  J Natl Cancer Inst       Date:  1958-06       Impact factor: 13.506

3.  RETENTION OF MULTIPLE DEVELOPMENTAL POTENTIALITIES BY CELLS OF A MOUSE TESTICULAR TERATOCARCINOMA DURING PROLONGED CULTURE in vitro AND THEIR EXTINCTION UPON HYBRIDIZATION WITH CELLS OF PERMANENT LINES.

Authors:  B W Finch; B Ephrussi
Journal:  Proc Natl Acad Sci U S A       Date:  1967-03       Impact factor: 11.205

4.  Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours.

Authors:  P W Andrews; J Casper; I Damjanov; M Duggan-Keen; A Giwercman; J Hata; A von Keitz; L H Looijenga; J L Millán; J W Oosterhuis; M Pera; M Sawada; H J Schmoll; N E Skakkebaek; W van Putten; P Stern
Journal:  Int J Cancer       Date:  1996-06-11       Impact factor: 7.396

5.  The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture.

Authors:  G R Martin; M J Evans
Journal:  Cell       Date:  1974-07       Impact factor: 41.582

6.  The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos.

Authors:  L C Stevens
Journal:  Dev Biol       Date:  1970-03       Impact factor: 3.582

7.  Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds.

Authors:  S Morais da Silva; A Hacker; V Harley; P Goodfellow; A Swain; R Lovell-Badge
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

8.  Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors.

Authors:  R J van Gurp; J W Oosterhuis; V Kalscheuer; E C Mariman; L H Looijenga
Journal:  J Natl Cancer Inst       Date:  1994-07-20       Impact factor: 13.506

9.  Experimental testicular germ cell tumorigenesis in mouse strains with and without spontaneous tumours differs from development of germ cell tumours of the adult human testis.

Authors:  H Walt; J W Oosterhuis; L C Stevens
Journal:  Int J Androl       Date:  1993-08

10.  Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935-1992.

Authors:  T Zheng; T R Holford; Z Ma; B A Ward; J Flannery; P Boyle
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

View more
  2 in total

1.  Characterization of pluripotent stem cells.

Authors:  Mercè Martí; Lola Mulero; Cristina Pardo; Cristina Morera; Meritxell Carrió; Leopoldo Laricchia-Robbio; Concepcion Rodriguez Esteban; Juan Carlos Izpisua Belmonte
Journal:  Nat Protoc       Date:  2013-01-10       Impact factor: 13.491

2.  Neonatal Porcine Germ Cells Dedifferentiate and Display Osteogenic and Pluripotency Properties.

Authors:  Mohammad Amin Fayaz; Gustavo Dos Santos Rosa; Ali Honaramooz
Journal:  Cells       Date:  2021-10-20       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.